This site use cookies
This site uses cookies that help us to improve our site by providing analytics and usage information. By clicking accept or continuing to use this site you are agreeing to our cookie policy. If you do not agree, please close this notice. Learn more

Dr John Kurek



John is the Biotechnology Investment Manager at Uniseed, a venture fund operating at the Universities of Melbourne, Queensland, Sydney, New South Wales, and the CSIRO, with investment capital provided by the five partner research organisations. He brings 20 years’ industry experience as a Biotechnology Manager with a focus on the strategic design and implementation of drug development programs. 

John’s previous roles have included Pharmaceutical Development Manager at BioDiem Ltd, where he was responsible for managing the preclinical, clinical and regulatory aspects of BioDiem’s drug development programs, and Preclinical Development Manager at Amrad Corporation Ltd where he was responsible for the management of preclinical drug development projects.  His experience extends from drug discovery, to the phase I-II clinical phases of drug development.

John has a PhD in Neuroscience and a Post Graduate Diploma in Drug Evaluation and Pharmaceutical Science, both from the University of Melbourne and is a Graduate of the Australian Institute of Company Directors.